Current Status and Progress in Stem Cell Therapy for Intracerebral Hemorrhage
Translational Stroke Research · 2025-04 · 16 (2) · 512-534
DOI: 10.1007/s12975-023-01216-7 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Translational Stroke Research, online erschienen am 25.11.2023. Verfasst von Ning Ding und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery and Key Laboratory of Neurotrauma, Southwest Hospital, Third Military Medical University (Army Medical University), Chongq…. Hauptthemen laut MEDLINE: Cerebral Hemorrhage, Stem Cell Transplantation. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 166 Literaturangaben.
Abstract (Originalsprache)
Intracerebral hemorrhage is a highly prevalent and prognostically poor disease, imposing immeasurable harm on human life and health. However, the treatment options for intracerebral hemorrhage are severely limited, particularly in terms of improving the microenvironment of the lesion, promoting neuronal cell survival, and enhancing neural function. This review comprehensively discussed the application of stem cell therapy for intracerebral hemorrhage, providing a systematic summary of its developmental history, types of transplants, transplantation routes, and transplantation timing. Moreover, this review presented the latest research progress in enhancing the efficacy of stem cell transplantation, including pretransplantation preconditioning, genetic modification, combined therapy, and other diverse strategies. Furthermore, this review pioneeringly elaborated on the barriers to clinical translation for stem cell therapy. These discussions were of significant importance for promoting stem cell therapy for intracerebral hemorrhage, facilitating its clinical translation, and improving patient prognosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurosurgery and Key Laboratory of Neurotrauma, Southwest Hospital, Third Military Medical University (Army Medical University), Chongqing, 400038, China.
- Clinical Medical Research Center, Southwest Hospital, Third Military Medical University (Army Medical University), Chongqing, 400038, China.
- Department of Neurosurgery and Key Laboratory of Neurotrauma, Southwest Hospital, Third Military Medical University (Army Medical University), Chongqing, 400038, China. huchrong@tmmu.edu.cn.
Zitieren
APA
Ding, N., Luo, R., Zhang, Q., Li, H., Zhang, S., Chen, H., & Hu, R. (2025). Current Status and Progress in Stem Cell Therapy for Intracerebral Hemorrhage. Translational Stroke Research, 16(2), 512-534. https://doi.org/10.1007/s12975-023-01216-7
Vancouver
Ding N, Luo R, Zhang Q, Li H, Zhang S, Chen H, et al. Current Status and Progress in Stem Cell Therapy for Intracerebral Hemorrhage. Translational Stroke Research. 2025;16(2):512-534. doi:10.1007/s12975-023-01216-7
BibTeX
@article{Ding2025,
author = {Ding, Ning and Luo, Ran and Zhang, Qian and Li, Huanhuan and Zhang, Shuixian and Chen, Huanran and Hu, Rong},
title = {Current Status and Progress in Stem Cell Therapy for Intracerebral Hemorrhage},
journal = {Translational Stroke Research},
year = {2025},
volume = {16},
number = {2},
pages = {512--534},
doi = {10.1007/s12975-023-01216-7}
}
EUVIMED